| Gene symbol | TNFSF13B | Synonyms | BAFF, BLYS, CD257, DTL, TALL-1, TALL1, THANK, TNFSF20, TNLG7A, ZTNF4 | Type of gene | protein-coding |
| Chromosome | 13 | Map location | 13q33.3 | dbXrefs | |
| Description | TNF superfamily member 13b | ||||
| GTO ID | GTC3187 |
| Trial ID | NCT05546723 |
| Disease | Multiple Myeloma |
| Altered gene | BAFF |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LMY-920 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | LMY-920 for Treatment of Relapsed or Refractory Myeloma |
| Year | 2022 |
| Country | United States |
| Company sponsor | Luminary Therapeutics |
| Other ID(s) | LMY-920-002|LUMT1A22 |
| Cohort 1 | |||||||||
|
|||||||||